Theratechnologies
Presence
Theratechnologies is one of the...
Theratechnologies is a company listed under the stock ticker TH (CA).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Theratechnologies
- Paul Lévesque, Director, President and Chief Executive Officer
- Dawn Svoronos, Director
- Gerald Lacoste, Corporate Director
Popular executive movements at Theratechnologies
- Frank Holler, who was Director, is promoted to Chairman of the Board (posted on May 13 2024).
- Elina Tea has joined the company as Director (posted on April 8 2024).
- Jordan Zwick has joined the company as Director (posted on March 22 2024).
Click here to view some more movements at Theratechnologies
Create your alert
to follow the executive moves at Theratechnologies.
Pharmaceuticals
Theratechnologies has 1,860 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Theratechnologies
- Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference | Theratechnologies Inc.
- Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens | Theratechnologies Inc.
- Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement | Theratechnologies Inc.
- Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies | Theratechnologies Inc.
- Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update | Theratechnologies Inc.
- Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management | Theratechnologies Inc.
- CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal | Theratechnologies Inc.
- Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Update | Theratechnologies Inc.
- Press Releases | Theratechnologies Inc.
- Theratechnologies Announces New Head of Investor Relations | Theratechnologies Inc.
- View more press releases Close
Social media about Theratechnologies
- Theratechnologies on Wikipedia, Google News & Yahoo Finance
- Theratechnologies on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Paul Lévesque 
Call Theratechnologies at +1 514...
